MedPath

Compare the effect of combined methylergonovine pill and combined oral contraceptive low dose (LD) with methylergonovine and LD pills alone on bleeding caused by retention product of pregnancy after first trimester of abortio

Not Applicable
Conditions
Retained products of conception.
Early fetal death with retention of dead fetus
Registration Number
IRCT2013070213845N1
Lead Sponsor
Vice chancellor for Research, Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
111
Inclusion Criteria

Inclusion Criteria: woman with age between 20-35 first trimester abortion with bleeding or sonography that show retain tissue, HB 11 gr/dl or more, no history of angina, Myocardial infarction, Cardiovascular disease, Coronary artery disease, no history of Cerebrovascular Diseases, Transient ischemic attacks and Severe migraine, no history of Eclampsia and pre eclampsia, Severe hypertension, Peripheral arterial occlusive disease, no history of Thrombophlebitis and thromboembolic disorders, no history of Liver adenoma, Carcinoma or Benign tumors of the liver, Liver dysfunction and acute liver disease, No-smoking
exclusion criteria: Unwillingness to cooperate, Allergic reactions to medicines, Hemoglobin decreased during the study (10 gr/dl or less)

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Complete pass of residual products of conception. Timepoint: After the intervention period. Method of measurement: Sonography.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath